Literature DB >> 34492151

Coordinating physiotherapy care for persons with haemophilia.

Merel A Timmer1,2, Johan Blokzijl1,2, Roger E G Schutgens1, Cindy Veenhof2,3, Martijn F Pisters4.   

Abstract

INTRODUCTION: Physiotherapy is highly recommended for persons with haemophilia (PWH), to regain functioning after bleeding and to maintain functioning when dealing with haemophilic arthropathy. However, many PWH live too far from their Haemophilia Comprehensive Care Centre (HCCC) to receive regular treatment at their HCCC. Physiotherapists in primary care may have limited experience with a rare disease like haemophilia. AIM: To explore experiences of stakeholders with primary care physiotherapy for PWH and develop recommendations to optimize physiotherapy care coordination.
METHODS: A RAND approach was used, consisting of a Delphi procedure with e-mailed questionnaires and a consensus meeting. Included stakeholders were PWH, physiotherapists from HCCC's and primary care physiotherapists. HCCC physiotherapists approached patients from their centre and primary care physiotherapists from their network to fill in the questionnaires. Purposive sampling was used to select participants from the survey sample for the consensus meeting.
RESULTS: Ninety-six primary care physiotherapists, 54 PWH and eight HCCC physiotherapists completed the questionnaire. Subsequently, four PWH, three primary care physiotherapists and four HCCC physiotherapists participated in the consensus meeting. The questionnaires yielded 33 recommendations, merged into a final list of 20 recommendations based on the consensus meeting. The final rank-order consists of 13 recommendations prioritized by at least one stakeholder.
CONCLUSION: Commitment to a formal network is considered not feasible for a rare disease like haemophilia. Development of a practice guideline, easy-accessible information and contact details, two-way and open communication between HCCC and primary care and criteria to refer back to the HCCC are recommended.
© 2021 The Authors. Haemophilia published by John Wiley & Sons Ltd.

Entities:  

Keywords:  care coordination; comprehensive care; haemophilia; physiotherapy; primary care; rare disease

Mesh:

Year:  2021        PMID: 34492151      PMCID: PMC9292005          DOI: 10.1111/hae.14404

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.263


INTRODUCTION

With a prevalence of one in 10,000 individuals, haemophilia is a rare disease. Between 6 and 8% of the community suffers from a rare disease. This translates to 30 million people in the European Union alone. To improve health care for persons with a rare disease, several international strategies were developed, including EURORDIS and the European Reference Networks (ERN) in Europe and the Rare Disease Act in the United States. , An important aim of these strategies is to bundle expertise in expert centres and link expert centre to increase knowledge. The European Association for Haemophilia and Allied Disorders (EAHAD) already has a long and stable history of accrediting European Haemophilia Comprehensive Care Centre (HCCC) in order to bundle expertise for persons with haemophilia (PWH). According to the EAHAD guidelines, access to physiotherapy is one of the requirements to become an HCCC. Physiotherapy treatment is recommended in addition to clotting factor replacement therapy in case of acute bleeding and as a conservative management strategy for HA related complaints. , , Whereas clotting factor replacement therapy is the first priority when a bleed occurs, physiotherapy following acute bleeding is directed at return to activities (daily activities, work, school, sports) and prevention of recurrent bleeding. Despite the introduction of prophylactic clotting factor replacement therapy, two bleeds per year on average still occur in persons with severe haemophilia with access to prophylactic replacement therapy. For persons with haemophilic arthropathy (HA) as a consequence of bleeding in the past, physiotherapy is directed at retaining and optimizing daily functioning. Positive effects were found for several exercise interventions developed for PWH. Unfortunately, many PWH will not have access to regular physiotherapy treatment by a physiotherapist located at their HCCC, since there are only a few accredited centre in every region. Treatment in primary care could be a solution to increase accessibility of physiotherapy treatment. However, given the rare nature of the disease, physiotherapists in primary care may have limited experience with the treatment of haemophilia. The importance of multidisciplinary care for persons with chronic diseases is widely accepted. However, literature about a primary care approach for chronic rare disease is still lacking. The aim of the current study is to explore the experiences of stakeholders with primary care physiotherapy for PWH and develop recommendations to optimize physiotherapy care coordination.

METHODS

Study design

This study uses the RAND method. The RAND method is a hybrid of the Delphi method (using e‐mailed questionnaires) and a consensus meeting according to the Nominal Group Technique (NGT). The RAND method therefore allows for the inclusion of a large representative sample during the survey phase and enables stakeholders to perform in‐depth discussion and get insight into each other's point of view during the consensus meeting. The research protocol was approved by the Institutional Review Board of the University Medical Center Utrecht, the Netherlands.

Participants

Stakeholders approached to participate in the study included patients, primary care physiotherapists and HCCC physiotherapists. PWH or von Willebrand's disease were eligible for inclusion if they had visited a primary care physiotherapist at least once, regardless of the indication. There was no restriction on severity or age. Parents were requested to participate for patients < 16 years. Patients were excluded if they had insufficient skills to read or write in Dutch. Primary care physiotherapists were eligible for inclusion when they had treated at least one PWH or von Willebrand's disease, for any indication. All (paediatric) physiotherapists located at an HCCC in the Netherlands were eligible for inclusion.

Procedure and data analysis

Phase 1: Survey

Three different questionnaires were developed for de different stakeholders (PWH, primary care physiotherapists and HCCC physiotherapists). The researchers drafted a first version of the questionnaires. A patient‐representative, a primary care physiotherapist and a HCCC physiotherapist not included in the study reviewed the questionnaires and provided them from feedback. The questionnaires were adjusted until they were approved by all stakeholders. Between January and August of 2020 (parents of) PWH or von Willebrand's disease, HCCC physiotherapists and primary care physiotherapists in the Netherlands were approached to participate in the study. Physiotherapists in the Dutch HCCC's approached patients from their own centre and primary care physiotherapists from their network. All participants were required to fill out a questionnaire, send by email through the electronic data capture system ‘Castor’. At the end of the questionnaire participants were able to indicate whether they wanted to be approached for a consensus meeting. Responses to closed‐ended questions in the questionnaire were described as proportions, means and standard deviations (SD) or medians and quartiles for not normally distributed data. Open‐ended questions were analysed using a thematic approach. Recommendations generated by both open‐ended and closed‐ended questions were listed by the researchers.

Phase 2: Consensus meeting

Purposive sampling (for physiotherapists based on specialization and experience and for PWH based on age and indication for physiotherapy treatment) was used to select four PWH, four HCCC physiotherapists and four primary care physiotherapists to participate in the subsequent consensus meeting. Prior to the consensus meeting, the recommendations listed by the researchers at the end of phase 1 were presented to the participants. A digital consensus meeting was performed according to NGT principles. During the consensus meeting participants were invited to clarify ideas and explain the importance from their point of view. Based on the discussion recommendations were adjusted, merged, split or added. Two researchers (J.B. and M.T.) acted as moderators. After the consensus meeting participants were asked to anonymously prioritize their five most important recommendations to optimize primary care physiotherapy for PWH. The NGT enabled participants to be involved in data‐analysis by composing a rank‐order. Recommendations were scored based on their position in the priority lists (the most important recommendation received a score of 5, the most important recommendation after that received a score of 4, etc.).

RESULTS

A total of 96 primary care physiotherapists, 54 PWH and eight HCCC physiotherapists completed the questionnaires (response rate of, respectively, 23%, 73% and 57%). Characteristics of the primary care physiotherapists, PWH and HCCC physiotherapists that filled out the questionnaires are presented in Tables 1, 2, 3, respectively. Subsequently, 74 PWH and physiotherapists indicated that they wanted to be approached for a consensus meeting. Of the 12 purposively sampled stakeholders, 11 (4 PWH, three primary care physiotherapists and four HCCC physiotherapists) actually participated in the consensus meeting.
TABLE 1

Characteristics of primary care physiotherapists (n = 96)

Experience as physiotherapist, mean years (sd)22.6 (12)
Specialization, % (n)
Paediatrics14.6 (14)
Sports18.8 (18)
Manual therapy29.2 (28)
Geriatrics3.1 (3)
Patients with haemophilia treated, % (n)
157.3 (55)
2–1040.6 (39)
 > 102.1 (2)
Indication for which they treated a PWH, % (n)
Joint bleed47.9 (46)
Muscle bleed38.5 (37)
Synovitis16.7 (16)
HA32.3 (31)
Not haemophilia related problem in PWH52.1 (50)

Abbreviations: HA, Haemophilic Arthropathy; PWH, person with haemophilia.

TABLE 2

Characteristics of persons with haemophilia (n = 56)

Age, mean years (sd)40.1 (20.2) Range 8–75
Disorder, % (n)
Severe haemophilia60.7 (34)
Moderate haemophilia16.1 (9)
Mild haemophilia19.6 (11)
Von Willebrand's disease3.6 (2)
Indication for received PT treatment, % (n)
Joint bleed46.4 (26)
Muscle bleed25.0 (14)
Synovitis28.6 (16)
HA51.8 (29)
Not haemophilia related problem in PWH41.1 (23)

Abbreviations: HA, Haemophilic Arthropathy; PWH, persons with haemophilia; PT, physiotherapy.

TABLE 3

Characteristics of physiotherapists located at a haemophilia comprehensive care centre (n = 8)

Experience as physiotherapist, median years (IQR)20.5 (8.25–38.0)
Specialization, % (n)
Paediatrics50 (4)
Geriatrics12.5 (1)
No specialization37.5 (3)
Experience with haemophilia care, median years (IQR)10 (2–17)
Hours for haemophilia care per week, median fte (IQR).2 (.05–.8)
Physiotherapists that have previously referred a PWH to primary care, % (n)87.5 (7)
Indication for referral to primary care, % (n)
Joint bleed50 (4)
Muscle bleed75 (6)
Synovitis37.5 (3)
HA37.5 (3)
Not haemophilia related problem in PWH62.5 (5)

Abbreviations: HA, Haemophilic Arthropathy; PWH, persons with haemophilia.

Characteristics of primary care physiotherapists (n = 96) Abbreviations: HA, Haemophilic Arthropathy; PWH, person with haemophilia. Characteristics of persons with haemophilia (n = 56) Abbreviations: HA, Haemophilic Arthropathy; PWH, persons with haemophilia; PT, physiotherapy. Characteristics of physiotherapists located at a haemophilia comprehensive care centre (n = 8) Abbreviations: HA, Haemophilic Arthropathy; PWH, persons with haemophilia.

Phase 1: survey

All three questionnaires included the domains; (1) general information, (2) experiences with primary care physiotherapy for PWH, (3) experiences with cooperation between primary care and HCCC, and (4) desired cooperation. The domain ‘general information’ ended with the open question ‘How do you think we can improve physiotherapy for PWH in primary care and what do you think is needed to achieve that?’ The other domains all ended with the question ‘Is there anything you want to add about this topic?’. All other questions where closed‐ended questions. Questionnaires are attached within Appendix 1.

Experiences with primary care physiotherapy for PWH

Treatment modalities applied for joints bleeds, muscle bleeds, synovitis and HA as indicated by patients and primary care physiotherapists are shown in Figure 1(A–D), respectively. Physiotherapists stated that they used a median number of 8 (IQR 4–12) treatment sessions for joint bleeds, 6 (IQR 4–10) for muscle bleeds, 9.5 (IQR 5–16.5) for synovitis and 15 (IQR 9–24) for haemophilic arthropathy. PWH recall a number of 6 (IQR 3.8‐11.3) treatment sessions for joints bleeds, 5 (IQR 3–15) for muscle bleeds, 8.5 (IQR 2–45) for synovitis and 10 (4.5‐41) for haemophilic arthropathy.
FIGURE 1

(A–D). Treatment modalities used for the treatment of (A) joint bleeds, (B) muscle bleeds, (C) haemophilic arthropathy, D) synovitis as indicated by patients (striped bar) and primary care physiotherapists (empty bar)

(A–D). Treatment modalities used for the treatment of (A) joint bleeds, (B) muscle bleeds, (C) haemophilic arthropathy, D) synovitis as indicated by patients (striped bar) and primary care physiotherapists (empty bar) Of the primary care physiotherapists that have treated a PWH with a joint bleed, 39.6% (19/48) indicated that they lack knowledge and experience to provide sufficient quality of care. For muscle bleeds, synovitis and HA this was, respectively, 42.2% (16/38), 37.5% (6/16) and 43.8% (14/32). Of the PWH, 32.1% felt that the primary care physiotherapist did not have enough information about haemophilia, and 19.6% felt that the primary care physiotherapist did not have enough information about their specific situation.

Experienced and desired collaboration

Overall, 73.2% of the patients, 58.2% of the primary care physiotherapists and 57.1% of the HCCC physiotherapists were positive about the collaboration between primary care and HCCC. Table 4 shows differences between experiences and preferences on specific items regarding collaboration between primary care physiotherapists and HCCC physiotherapists. Most primary care physiotherapists (54.2%) prefer to consult the HCCC at least once and in case of questions or problems. This is in accordance with HCCC physiotherapists (42.8%), although some HCCC physiotherapists feel this should be continued monthly for the duration of the treatment (43.0%). A monthly report is not recommended by primary care physiotherapists (2.2%).
TABLE 4

Experiences versus preferences in collaboration between primary care physiotherapists and HCCC physiotherapists

ExperiencePreferred
A referral received by the primary care physiotherapist54.1% [42.0–63.0]74.0% [64.0–85.4]
A medical handover received by the primary care physiotherapist56.3% [45.6–66.4]86.5% [78.0–92.6]
Information about the patient's specific situation received by the primary care physiotherapist29.2% [20.0–39.3]63.5% [53.1–73.1]
Information to align treatment with other caregivers received by the primary care physiotherapist30.2% [21.3–40.4]71.9% [61.8–80.6]
A specific care plan for the patient received by the primary care physiotherapist44.8% [34.5–55.3]75% [65.1–83.3]
An end report received by the HCCC physiotherapist28.6% [.037–.71]57.1% [.18–.90]

Results are presented in percentages with confidence intervals.

Abbreviation: HCCC = haemophilia comprehensive care centre.

Experiences versus preferences in collaboration between primary care physiotherapists and HCCC physiotherapists Results are presented in percentages with confidence intervals. Abbreviation: HCCC = haemophilia comprehensive care centre. From the open‐ended questions several themes to improve physiotherapy in primary care evolved, including challenges and recommendations. Both primary care physiotherapist and PWH indicated the little knowledge of primary care physiotherapists about haemophilia as a challenge. Given the small incidence, primary care physiotherapists find it difficult to gain experience and invest time to gain knowledge. PWH think that primary care physiotherapists feel a barrier to cooperate with HCCC physiotherapists. Both PWH, primary care physiotherapists and HCCC physiotherapists put forward three main recommendations: inform primary care physiotherapists about haemophilia, improve collaboration between primary care and HCCC and build a network of primary care physiotherapists with experience in haemophilia care.

Phase 2: Consensus meeting

The initial questionnaires yielded 33 recommendations for improvement. Based on the consensus meeting these were merged into a final list of 20 recommendations. A total of 13 recommendations was prioritized by at least one stakeholder. The final list of recommendations is presented in Table 5. One of the recommendations that was not prioritized by any of the stakeholders is the formation of a formal network of physiotherapists, including commitment to following education and treatment according to guidelines. In contrary, items with a high rank on the final list include the development of a practice guideline of the treatment of PWH (1), easy‐accessible information and contact details (2) and two‐way and open communication between HCCC physiotherapists and primary care physiotherapists (4).
TABLE 5

List of recommendations

RankRecommendationScore a Number of participants that prioritized the recommendation (N = 11)
1Create a formal practice guideline for treatment of PWH in primary care. This guideline will consist of written information on the most recent scientific evidence and expertise from healthcare professionals.299
2Ensure that Information about haemophilia, treatment options and contact details of HCCC physiotherapists are easily accessible (e.g., on a website).288
3Improve reimbursement by insurance companies for physiotherapy treatment of PWH in primary care.258
4Ensure two‐way and open communication between primary care physiotherapists and HCCC physiotherapists (e.g., by enabling direct contact between physiotherapists or by letting the HCCC physiotherapist initiate a call to the primary care physiotherapist)226
5Provide a decision tool to help primary care physiotherapist determine when they should contact the HCCC when they treat PWH with all sorts of physical complaints (joint of muscle bleedings, synovitis or arthropathy)195
6Ensure sufficient physiotherapy service and if needed expand the number of available hours for HCCC physiotherapists (for treatment within the HCCC and for collaboration with primary care physiotherapists)134
7Provide education to primary care physiotherapists about haemophilia (either physical or digital)63
8Refer PWH for treatment to a physiotherapist with previous experience in treatment of PWH when possible63
9Set up a digital register or map for PWH to find a primary care physiotherapist with previous experience in treatment of PWH in their neighbourhood62
10HCCC physiotherapists should ask PWH about primary care physiotherapy during periodic visits52
11Provide available diagnostic imaging (X‐ray and/or Ultrasound) to primary care physiotherapists33
12Ensure communication between the primary care physiotherapist and the physiotherapist from the HCCC is accessible for the PWH21
13Ensure communication between the primary care physiotherapist and the HCCC physiotherapist whenever treatment in primary care is terminated.11
Provide written information about periodic visits at the HCCC to the primary care physiotherapist.00
Ask patients to bring, or send, a report from the primary care physiotherapist to the periodic visit at the HCCC.00
Always start physiotherapy treatment in the HCCC00
Involve a PWH and/or family of this person in creating treatment goals.00
Start a formal network for physiotherapists. Participating physiotherapists will commit to following education and treat patients according to guidelines.00
Start regional physical therapy training groups led by a physiotherapist.00
Provide insight into the number of PWH living in a certain area.00

Abbreviations: HCCC, haemophilia comprehensive care centre, PWH, persons with haemophilia, PC = Primary care.

Score is based on the position of the recommendation on the priority lists of the participants (the most important recommendation received a score of 5, the most important recommendation after that received a score of 4, etc.).

List of recommendations Abbreviations: HCCC, haemophilia comprehensive care centre, PWH, persons with haemophilia, PC = Primary care. Score is based on the position of the recommendation on the priority lists of the participants (the most important recommendation received a score of 5, the most important recommendation after that received a score of 4, etc.).

DISCUSSION

Experiences of primary care physiotherapists with the treatment of haemophilia related problems showed that between 37.5 and 43.8% felt they lacked knowledge and experience to provide sufficient quality of care. A smaller part of the PWH felt that the primary care physiotherapist did not have enough information about haemophilia (32.1%) or their specific situation (19.6%). The majority of PWH (73.2%), primary care physiotherapists (58.2%) and HCCC physiotherapist (57.1%) were positive about the collaboration between primary care and HCCC. To optimize quality of physiotherapy care stake‐holders propose to develop a practice guideline, provide easy‐accessible information and contact details, ensure two‐way and open communication between HCCC physiotherapists and primary care physiotherapists and provide criteria to refer back to the HCCC. The formation of a formal network of physiotherapists was not prioritized in the final list of recommendations. Content of physiotherapy practice for PWH is investigated in one previous European survey. This survey was filled out by HCCC physiotherapists and gives a general description of applied treatment modalities, without differentiation between conditions. However, similar to the current study, exercise therapy was mostly applied and in about half of the cases manual therapy was used. In contrast to the current study, education about the condition was given more often in the European survey. This could be explained by the fact that primary care physiotherapists in the current study felt they lacked knowledge about haemophilia, whereas HCCC physiotherapists in the previous study probably have more knowledge about the condition. Furthermore, the use of e‐health solutions to improve physiotherapy care for PWH is recommended in recent literature and implementation has been accelerated by the COVID‐19 pandemic. , Although, the use of e‐health was not specifically mentioned in the current study, it may be useful to facilitate the implementation of treatment recommendations in the future. Literature about physiotherapy care coordination for persons with rare diseases in general and PWH in particular is not yet available. Comprehensive care models in haemophilia are primarily directed at multidisciplinary care within the HCCC . However, according to the conceptual framework for integrated care by Valentijn and colleagues comprehensive care includes vertical and horizontal integration. Pathways that connect community‐based generalists with hospital‐sited specialists are considered vertical integration, whereas horizontal integration involves collaboration between different professions within one organization. Different techniques are required to achieve them. In accordance with this framework, results from the current study emphasize the importance of vertical integration and proposes steps to improve vertical integration in physiotherapy care for patients with a rare chronic disease like haemophilia. Previous research shows that the implementation of a formal physiotherapy network for Parkinson's disease (the Dutch ParkinsonNet) resulted in lower health care costs and less complications. Formal physiotherapy networks are also being developed for several other chronic diseases, including Chronic Obstructive Pulmonary Disease, Rheumatoid Arthritis and Intermitted Claudication. , Although differences in approach exist between networks and between countries, they usually include mandatory education for participating professionals, building of guidelines and commitment of professionals to guidelines. The current study shows that commitment to a formal network is not feasible for a rare chronic disease. Recommendations in the current study aim to improve disease specific knowledge in a way, that is, feasible for a rare chronic disease. A strength of the current study is the use of a RAND procedure, including a survey phase and a consensus meeting. By starting with a survey with a large sample size, we increased generalizability of the results. The advantage of the subsequent consensus meeting is that it enables stakeholders to get insight into each other's point of view, resulting in more in‐depth results. A possible limitation of the study is the use of a digital consensus meeting. Literature about the validity of digital variants of focus group techniques is still lacking. However, the moderators ensured that all stakeholders participated in the discussion and within the NGT all participants contribute by making a rank‐order of the proposed items. Furthermore, the use of a digital consensus meeting reduces selection bias, because it is less time‐consuming considering participants do not have to travel. Results of the current study can be generalized to countries with a similar health care system as the Netherlands. Differences in roles, responsibilities and clinical practice of physiotherapists between countries and even between different institutes may influence the needs and possibilities for primary care physiotherapy. Although this study was directed at the treatment of PWH, it can be expected that results are applicable for other rare chronic diseases as well given the general nature of the recommendations. Future research is needed to demonstrate whether similar results are found in other rare chronic conditions and in countries with a different health care system. To conclude, the majority of the stakeholders is positive about the collaboration between HCCC and primary care physiotherapists. However, up to half of the primary care physiotherapists feel that they have insufficient knowledge and experience to provide sufficient quality of care and up to a third of the PWH feel that their physiotherapist lacks information. Commitment to a formal network is considered not feasible for a rare chronic disease. Development of a practice guideline, easy‐accessible information and contact details, two‐way and open communication between HCCC and primary care and criteria to refer back to the HCCC are recommended.

CONFLICT OF INTEREST

The authors stated they have no competing interests.

AUTHOR CONTRIBUTIONS

Merel A. Timmer an Martijn F Pisters developed the study. Merel A. Timmer and Johan Blokzijl performed data collection. All authors contributed to data interpretation. All authors contributed to critical reviewing and editing of the manuscript. All authors approved the final manuscript. Appendix 2 Click here for additional data file.
  17 in total

1.  ParkinsonNet: A Low-Cost Health Care Innovation With A Systems Approach From The Netherlands.

Authors:  Bas R Bloem; Lonneke Rompen; Nienke M de Vries; Ab Klink; Marten Munneke; Patrick Jeurissen
Journal:  Health Aff (Millwood)       Date:  2017-11       Impact factor: 6.301

2.  The clinical effectiveness of the COPDnet integrated care model.

Authors:  E H Koolen; B van den Borst; M de Man; J C Antons; B Robberts; P N R Dekhuijzen; J H Vercoulen; M van den Heuvel; M A Spruit; P J van der Wees; A J van 't Hul
Journal:  Respir Med       Date:  2020-09-12       Impact factor: 3.415

3.  The European standards of Haemophilia Centres.

Authors:  Paul Giangrande; Gabriele Calizzani; Ivana Menichini; Fabio Candura; Pier Mannuccio Mannucci; Michael Makris
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 4.  Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline.

Authors:  J Hanley; A McKernan; M D Creagh; S Classey; P McLaughlin; N Goddard; P J Briggs; S Frostick; P Giangrande; J Wilde; J Thachil; P Chowdary
Journal:  Haemophilia       Date:  2017-03-30       Impact factor: 4.287

Review 5.  Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations.

Authors:  C Hermans; P De Moerloose; K Fischer; K Holstein; R Klamroth; T Lambert; G Lavigne-Lissalde; R Perez; M Richards; G Dolan
Journal:  Haemophilia       Date:  2011-02-15       Impact factor: 4.287

6.  Scope of practice of haemophilia physiotherapists: A European survey.

Authors:  David Stephensen; Piet de Kleijn; Ruth Elise D Matlary; Marie Katzerova; Paul McLaughlin; Aislin Ryan; Sebastien Lobet
Journal:  Haemophilia       Date:  2019-03-13       Impact factor: 4.287

7.  Integrated multidisciplinary care for the management of chronic conditions in adults: an overview of reviews and an example of using indirect evidence to inform clinical practice recommendations in the field of rare diseases.

Authors:  C H T Yeung; N Santesso; D Zeraatkar; A Wang; M Pai; M Sholzberg; H J Schünemann; A Iorio
Journal:  Haemophilia       Date:  2016-07       Impact factor: 4.287

8.  Understanding integrated care: a comprehensive conceptual framework based on the integrative functions of primary care.

Authors:  Pim P Valentijn; Sanneke M Schepman; Wilfrid Opheij; Marc A Bruijnzeels
Journal:  Int J Integr Care       Date:  2013-03-22       Impact factor: 5.120

9.  A Blended Physiotherapy Intervention for Persons With Hemophilic Arthropathy: Development Study.

Authors:  Merel A Timmer; Corelien J J Kloek; Piet de Kleijn; Isolde A R Kuijlaars; Roger E G Schutgens; Cindy Veenhof; Martijn F Pisters
Journal:  J Med Internet Res       Date:  2020-06-19       Impact factor: 5.428

View more
  1 in total

1.  Coordinating physiotherapy care for persons with haemophilia.

Authors:  Merel A Timmer; Johan Blokzijl; Roger E G Schutgens; Cindy Veenhof; Martijn F Pisters
Journal:  Haemophilia       Date:  2021-09-07       Impact factor: 4.263

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.